| 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2025-005 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司 关于第四届董事会第三次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 珀莱雅化妆品股份有限公司（以下简称"公司"）第四届董事会第三次会议 通知于 2025 年 4 月 11 日以电子邮件方式送达全体董事，本次会议于 2025 年 4 月 23 日在公司会议室以现场方式召开。本次会议由董事长侯军呈先生主持，会 议应出席董事 5 人，实际出席董事 5 人，公司监事、高级管理人员列席本次会议。 本次董事会会议的召集、召开符合《中华人民共和国公司法》、《珀莱雅化妆品股 份有限公司章程》的有关规定，决议内容合法有效。 二、董事会会议审议情况 （一）审议通过《公司 2024 年度董事会工作报告》 表决结果：同意 5 票、反对 0 票、弃权 0 票。 本议案需提请公司股东大会审议。 （二）审议 ...

关于不向下修正"珀莱转债"转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2025-018 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司 2025 年 3 月 31 日至 2025 年 4 月 24 日，珀莱雅化妆品股份有限公司（以 下简称"公司"）股票在连续三十个交易日中有十五个交易日的收盘价低于当期 转股价格的 85%（82.80 元/股），已触发"珀莱转债"转股价格向下修正条款。 经公司第四届董事会第四次会议审议通过，公司董事会决定本次不向下 修正"珀莱转债"转股价格。并且在未来六个月内（即 2025 年 4 月 25 日至 2025 年 10 月 24 日），若"珀莱转债"触发向下修正条款，公司亦不向下修正"珀莱 转债"的转股价格。以 2025 年 10 月 24 日之后的首个交易日重新计算，若"珀 莱转债"再次触发向下修正条款，公司董事会将 ...

在回报股东方面，珀莱雅一直不遗余力，通过持续且丰厚的分红举措，彰显出公司对股东权益的高度重 视以及稳健发展的坚定信心。2024年年度报告显示，珀莱雅2024年度公司现金分红占2024年度合并报表 归属于上市公司股东净利润的40.07%，包括：拟每10股派发现金红利11.90元（含税）、拟分配现金红 利总额4.69亿元（含税）；2024年度集中竞价方式回购股份金额1.53亿元（含税）。自上市以来，珀莱 雅累计分红及回购金额已达20.02亿元（含2024年度拟分配的现金红利）。 据珀莱雅化妆品股份有限公司（股票代码：603605）近期发布的2024年年度报告显示，2024年度营业收 入同比增长21.04%，促使珀莱雅销售规模首次突破百亿元，实现收入107.78亿元；实现归母净利润 15.52亿元，同比增长30%；毛利率、净利率分别提升至71.39%和14.71%，核心经营指标均创历史新 高。2024年，珀莱雅依托"科技驱动产品、多品牌协同、全域渠道融合"，以卓越表现完成营收百亿元的 历史性突破，引领国货美妆行业迈向新高度，成为行业发展的标杆。 营收、净利创新高 上市以来累计分红及回购金额超20亿元 根据珀莱雅20 ...

珀莱雅化妆品股份有限公司 募集资金年度存放与使用情况鉴证报告 t with ri 目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 二、关于募集资金年度存放与使用情况的专项报告………………第 3—8 页 募集资金年度存放与使用情况鉴证报告 天健审〔2025〕6224 号 二、管理层的责任 珀莱雅公司管理层的责任是提供真实、合法、完整的相关资料，按照《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年修 订）》（证监会公告〔2022〕15 号）和《上海证券交易所上市公司自律监管指 引第 1 号——规范运作（2023 年 12 月修订）》（上证发〔2023〕193 号）的规 定编制《关于募集资金年度存放与使用情况的专项报告》，并保证其内容真实、 准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 三、注册会计师的责任 我们的责任是在实施鉴证工作的基础上对珀莱雅公司管理层编制的上述报 告独立地提出鉴证结论。 第 1 页 共 8 页 四、工作概述 我们按照中国注册会计师执业准则的规定执行了鉴证业务。中国注册会计师 执业准则要求我们计划和实施鉴证工作，以对鉴 ...

审计说明…………………………………………………………第 1—2 页 二、非经营性资金占用及其他关联资金往来情况汇总表…………第 3—3 页 非经营性资金占用及其他关联资金往来情况的 专项审计说明 天健审〔2025〕6225 号 珀莱雅化妆品股份有限公司 非经营性资金占用及其他关联资金 往来情况的专项审计说明 t with 目 录 一、非经营性资金占用及其他关联资金往来情况的专项 珀莱雅化妆品股份有限公司全体股东： 我们接受委托，审计了珀莱雅化妆品股份有限公司（以下简称珀莱雅公司） 2024 年度财务报表，包括 2024 年 12 月 31 日的合并及母公司资产负债表，2024 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公司所有者权 益变动表，以及财务报表附注，并出具了审计报告。在此基础上，我们审计了后 附的珀莱雅公司管理层编制的 2024 年度《非经营性资金占用及其他关联资金往 来情况汇总表》（以下简称汇总表）。 一、对报告使用者和使用目的的限定 本报告仅供珀莱雅公司年度报告披露时使用，不得用作任何其他目的。我们 同意将本报告作为珀莱雅公司年度报告的必备文件，随同其他文件一起报送并对 外披露。 ...

珀莱雅化妆品股份有限公司 内部控制审计报告 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表 审计意见，并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 目 录 一、内部控制审计报告…………………………………………第 1—2 页 内部控制审计报告 天健审〔2025〕6223 号 珀莱雅化妆品股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我 们审计了珀莱雅化妆品股份有限公司（以下简称珀莱雅公司）2024 年 12 月 31 日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》《企业内部控制应用指引》以及《企业内部 控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是珀莱 雅公司董事会的责任。 第 2 页 共 2 页 内部控制具有固有局限性，存在不能防止和发现错报的可能性。此外，由于 情况的变化可能导致内部控制变得不恰当，或对控制政策和程序遵循的程度降低， 根据内部控制审计结果推测未来内部控制的有效性具有一定风险。 四、财务报告内部控制审计意见 我们认为，珀 ...

Financial Performance - The company's operating revenue for Q1 2025 was CNY 2,359,334,894.91, representing an increase of 8.13% compared to CNY 2,181,919,106.72 in the same period last year[4]. - Net profit attributable to shareholders for the same period was CNY 390,281,697.93, reflecting a growth of 28.87% from CNY 302,845,157.17 year-on-year[4]. - Basic earnings per share rose to CNY 0.99, a 30.26% increase from CNY 0.76 in the previous year[4]. - Diluted earnings per share also increased to CNY 0.99, up 32.00% from CNY 0.75 year-on-year[5]. - Operating profit for Q1 2025 was ¥493,882,458.09, representing a 24.8% increase from ¥395,713,955.01 in Q1 2024[21]. - Net profit for Q1 2025 was ¥405,560,791.59, up 28.7% from ¥314,974,456.95 in Q1 2024[21]. - Other comprehensive income after tax for Q1 2025 was ¥122,936.85, compared to a loss of ¥48,390.37 in Q1 2024[22]. Cash Flow - The net cash flow from operating activities increased by 56.78%, amounting to CNY 675,490,380.59, primarily due to an increase in cash collections from customers[8]. - The net cash flow from operating activities increased to $675,490,380.59, up from $430,862,423.81, representing a growth of approximately 56.7% year-over-year[25]. - Total cash inflow from operating activities amounted to $2,761,025,865.44, compared to $2,689,148,254.33 in the previous period, indicating a slight increase of about 2.7%[25]. - Cash outflow from operating activities decreased to $2,085,535,484.85 from $2,258,285,830.52, reflecting a reduction of approximately 7.7%[25]. - The net cash flow from investing activities was negative at -$28,822,207.21, an improvement from -$79,661,124.91 in the prior period[25]. - Cash inflow from financing activities totaled $286,400.00, significantly higher than $50,000.00 previously, marking a growth of 472.8%[26]. - The net cash flow from financing activities was -$2,667,552.16, compared to -$155,071,599.45, showing a substantial improvement[26]. Assets and Liabilities - Total assets at the end of the reporting period reached CNY 8,201,525,310.98, an increase of 8.92% compared to CNY 7,530,182,694.00 at the end of the previous year[5]. - The company's current assets reached RMB 6,245,901,803.19, up from RMB 5,613,357,796.89, indicating an increase of about 11.2%[15]. - Total liabilities of the company amounted to RMB 2,266,174,338.94, up from RMB 1,992,556,238.53, indicating an increase of about 13.7%[16]. - The company's long-term debt, represented by bonds payable, was RMB 788,783,082.71, slightly up from RMB 780,011,293.32, indicating a marginal increase of about 1%[16]. - Total current liabilities increased to RMB 1,477,391,256.23 from RMB 1,212,544,945.21, reflecting a growth of about 21.9%[16]. - Total assets increased to ¥8,201,525,310.98 in Q1 2025, compared to ¥7,530,182,694.00 in Q1 2024[17]. - Total liabilities rose to ¥2,308,638,718.38 in Q1 2025, up from ¥2,043,934,843.04 in Q1 2024[17]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 50,966[10]. - Shareholders' equity attributable to the parent company was CNY 5,796,840,173.26, reflecting a growth of 7.31% from CNY 5,402,074,485.07 at the end of the last year[5]. - Total equity attributable to shareholders increased to ¥5,796,840,173.26 in Q1 2025, up from ¥5,402,074,485.07 in Q1 2024[17]. - The company has no significant changes in the top 10 shareholders or their participation in margin trading activities[12]. Compliance and Reporting - The company has committed to maintaining transparency and accuracy in its financial reporting, ensuring compliance with legal responsibilities[2]. - Non-recurring gains and losses for the period amounted to CNY 11,347,658.87 after tax, with significant contributions from government subsidies[7].

Financial Performance - The company's revenue for 2024 reached CNY 10,778,411,781.20, representing a 21.04% increase compared to CNY 8,904,573,501.39 in 2023[24]. - Net profit attributable to shareholders for 2024 was CNY 1,551,995,692.29, a 30.00% increase from CNY 1,193,868,141.81 in 2023[24]. - The basic earnings per share for 2024 was CNY 3.93, reflecting a 30.56% increase from CNY 3.01 in 2023[25]. - The company's total assets as of the end of 2024 were CNY 7,530,182,694.00, a 2.83% increase from CNY 7,323,078,222.45 at the end of 2023[24]. - The net cash flow from operating activities for 2024 was CNY 1,107,000,664.19, a decrease of 24.63% compared to CNY 1,468,793,814.58 in 2023[24]. - The company reported a weighted average return on equity of 32.53% for 2024, up from 29.94% in 2023, an increase of 2.59 percentage points[25]. - The total revenue for the company reached CNY 10,765,600,419.70, with a gross profit of CNY 3,077,384,979.23, resulting in a gross margin of 71.41%, which increased by 15.39% year-on-year[96]. - The company's sales expenses increased by CNY 1,188,810,892.03, reflecting a growth rate of 29.93% compared to the previous year[104]. Dividend and Shareholder Actions - The company plans to distribute a cash dividend of 11.90 RMB per 10 shares, totaling approximately 468.90 million RMB, which represents 40.07% of the net profit attributable to shareholders for the year 2024[6][7]. - The company executed a share buyback amounting to approximately 153.04 million RMB during the year 2024[6]. - The total number of shares for dividend calculation is based on 396,247,555 shares as of December 31, 2024, after excluding treasury shares[6]. - The company does not plan to increase capital reserves or issue bonus shares in the current dividend proposal[6]. Audit and Governance - The company has received a standard unqualified audit report from Tianjian Accounting Firm[5]. - The board of directors and senior management have ensured the accuracy and completeness of the annual report[3]. - The company has confirmed that all board members attended the board meeting to approve the annual report[4]. - The company has established a governance structure that includes a shareholders' meeting, board of directors, supervisory board, and specialized committees, ensuring clear responsibilities and effective checks and balances[191]. - The company has complied with the governance requirements set by the China Securities Regulatory Commission, with no significant discrepancies reported[191]. Market and Product Development - The company plans to continue expanding its market presence and investing in new product development to drive future growth[24]. - The company launched new product lines, including the "Source Power" series featuring a globally exclusive ingredient, and the "Optical" series targeting skin whitening[46][47]. - The company is exploring overseas market opportunities and adapting to rapid market changes through a flexible organizational structure[45]. - The company is committed to digital transformation, improving operational efficiency through SAP upgrades and product lifecycle management systems[187]. - The company is prioritizing the development of new channels, particularly on platforms like Tmall and Douyin, to enhance brand visibility and market position[177]. Marketing Strategies - The marketing strategy focused on themes of "youthfulness" and "technological strength," with various campaigns and events to engage consumers[48]. - The company launched a series of marketing campaigns, including collaborations with national-level IPs and brand ambassadors, to enhance brand visibility and sales[58]. - The company plans to optimize its Tmall operations by focusing on high-end and repair product lines, enhancing digital transformation, and improving conversion efficiency through live streaming[166]. - A new marketing strategy has been implemented, aiming to increase brand awareness by 40% in the next six months[196]. Research and Development - The company applied for a total of 64 new patents in 2024, including 35 invention patents, 12 utility model patents, and 17 design patents, while obtaining 25 new patents during the same period[78]. - The company established a European Innovation Center in Paris, enhancing its research capabilities alongside existing centers in Hangzhou and Shanghai[78]. - The company is investing heavily in R&D, with a budget increase of 30% for new technology development[196]. - Ongoing research and development efforts focus on creating differentiated technological barriers and enhancing product efficacy through clinical studies and innovative formulations[185]. Risks and Challenges - The company has outlined potential risks in its future development strategy, which investors should be aware of[10]. - The company faces risks related to intensified industry competition and potential underperformance in new brand and product category launches[188][189]. Customer Engagement and Satisfaction - The company has achieved a customer satisfaction rate of 90%, reflecting a strong performance in service delivery[200]. - Customer satisfaction ratings have improved, with a reported increase of 10% in positive feedback from users[196]. Future Outlook - The company has outlined a future outlook projecting a 20% growth in revenue for the next fiscal year[196]. - Future outlook indicates a projected revenue growth of 15% for the next fiscal year, driven by new product launches and market expansion strategies[198]. - The company is considering strategic acquisitions to enhance its market position, targeting firms with a combined revenue of 500 million[196].

商报讯(记者吕文鹃)在数字经济浪潮席卷全球的当下，化妆品行业正经历着从生产到消费的全链路变 革。近日，国货美妆龙头企业珀莱雅（603605），迎来了一项高管人事任命：4月14日，珀莱雅官宣任 命胡宁波为公司历史上的首位CDO(首席数字官)。 随着珀菜雅的快速发展，业务规模持续扩张，管理复杂度也日益提升，如何打破部门壁垒、实现数据资 产全域贯通，成为企业突破增长天花板的必答题。为此，珀莱雅设立首席数字官这一岗位，旨在从战略 层面构建数字化顶层设计，推动企业从"局部数字化升级"走向"全局数字化规划"。 数字化在珀莱雅这样的企业中扮演的角色早已今非昔比，作为珀莱雅首位CDO，胡宁波将统筹技术、 数据及业务等多个核心要素，围绕三大核心维度，为珀莱雅打造可持续的数字竞争力。 在胡宁波看来，"数字化转型的本质是用数字思维重构商业逻辑，而非单纯的技术堆砌。"为此，珀莱雅 将建立以ROI(投资回报率)为导向的"数字化价值评估体系"，确保技术投入能够精准转化为可量化的业 务增长，真正实现"数字力即竞争力"。 和许多快消品公司一样，珀莱雅的市场调研部门此前用问卷搜集消费者数据。当他们走到专柜一线，现 场搜集消费者反馈时，飞书语音 ...